Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors.[1] The focus of the journal is biotechnology including research results and the commercial business sector of this field. Coverage includes the related biological, biomedical, agricultural and environmental sciences. Also of interest are the commercial, political, legal, and societal influences that affect this field.[2]
 | |
| Discipline | Biotechnology |
|---|---|
| Language | English |
| Edited by | Barbara Cheifet |
| Publication details | |
Former name(s) | Bio/Technology |
| History | 1983–present |
| Publisher | Nature Portfolio (UK) |
| Frequency | Monthly |
| Hybrid | |
| 33.1 (2023) | |
| Standard abbreviations ISO 4 (alt) · Bluebook (alt1 · alt2) NLM (alt) · MathSciNet (alt  ) | |
| ISO 4 | Nat. Biotechnol. |
| Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus | |
| CODEN | NABIF9 |
| ISSN | 1087-0156 (print) 1546-1696 (web) |
| LCCN | 96647227 |
| OCLC no. | 34160925 |
| Links | |
The journal continues serial publication of the title "Bio/Technology", which had a publication period of 1983 to 1996.[3]
This journal is indexed in [4]
According to the Journal Citation Reports, the journal has a 2023 impact factor of 33.1, ranking it 2nd out of 158 journals in the category "Biotechnology & Applied Microbiology".[5]
  | This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |